Suono Bio

Revolutionizing targeted gastrointestinal treatments

Cambridge, United States · Founded 2017 · $8.8M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$8.8M
Last Round
$8.5M Series AJul 2021
Rounds
3

About

Suono Bio is a Foxborough, Massachusetts-based biotechnology company founded in 2017 as an MIT spinout that harnesses a proprietary ultrasound-based drug delivery platform to enable localized delivery of small molecules, biologics, nucleic acids, and gene therapies to the gastrointestinal tract without encapsulation. The platform, developed from 30 years of discoveries in MIT labs, can treat difficult-to-treat inflammatory and GI diseases with superior effectiveness compared to conventional systemic delivery. Backed by MIT's The Engine and Fujifilm, Suono Bio aims to revolutionize targeted GI therapeutics.

Summary

Suono Bio is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $8.8M in total across 3 rounds, most recently a $8.5M Series A round in Jul 2021. Investors include Axil Capital, Mizuho Securities Principal Investment and The Engine.

Funding History

Series ASeries AJul 2021
$8.5M

Sign up to see all 3 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Suono Bio on Indexed.vc
<a href="https://indexed.vc/companies/suono-bio"><img src="https://indexed.vc/api/badge/company/suono-bio" alt="Suono Bio on Indexed.vc" width="260" height="76" /></a>